Supratentorial tumors are subdivided into subependymoma (ST-SE) and two subgroups characterized by fusions: ST-EPN-RELA, characterized by expression of C11orf95-RELA fusion transcript and by exceptionally poor prognosis, and ST-EPN-YAP1, characterized by YAP1 fusions. The gene discussed is YAP1; the disease is subependymoma.